Stocks to Watch: Amylin, Barclays, Lincare, BrightPoint (Update 1)

NEW YORK -- Bristol-Myers Squibb ( BMY) is purchasing diabetes drugmaker Amylin Pharmaceuticals ( AMLN) in a deal valued at about $7 billion.

The companies said on Friday that Bristol-Myers would pay $31 a share in cash for San Diego-based Amylin. The deal includes Amylin's net debt and a payment obligation to Eli Lilly bringing the total value of the transaction to about $7 billion, the companies said.

The purchase price offers a 9.9% premium of to Amylin's closing share price Friday of $28.20.

Shares of Amylin rose 8.94% in premarket trading Monday to $30.72.

RIM: Berries Dying on the Vine


Barclays PLC ( BCS) said Monday its chairman has resigned.

Marcus Agius departs following the bank's $453 million settlement of an investigation into alleged interest rate manipulation.

Regulators in the U.S. and the U.K. alleged that Barclays had submitted false data for setting the London interbank offered rate, or Libor, between 2005 and 2009. Agius has been chairman at Barclays since the beginning of 2007.

Barclays shares rose 3.79% in premarket trading Monday to $10.69.


Technology distributor Ingram Micro ( IM) said Monday that it agreed to acquire wireless device distributor BrightPoint ( CELL) for $840 million, including debt.

The offer of $9 a share is a 66% premium to BrightPint's closing price Friday of $5.41.

Shares of BrightPoint jumped 61.18% in premarket trading Monday to $8.72.


Germany's Linde agreed to buy Lincare Holdings ( LNCR) for about $3.8 billion.

Under the deal, Linde will pay $41.50 a share for Lincare, a leader in the U.S. home respiratory market.

Lincare shares closed Friday at $34.02.

Shares of Lincare climbed 19.93% in premarket trading Monday to $40.80.


Apple ( AAPL) paid $60 million to Shenzhen Proview Technology to settle a dispute in China over ownership of the iPad name, a court announced Monday, according to a report from The Associated Press.

The deal removes a potential obstacle to sales of the iPad in China, a key market.

Apple shares ticked up $1.25, or 0.21%, in premarket trading Monday to $585.25.

Sirius XM Teetering on the Brink of Irrelevancy


Acuity Brands ( AYI)is expected by analysts Monday to post third-quarter earnings of 79 cents a share on revenue $492 million.

AB InBev Gulps Corona Maker For $21.1 Billion

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact